gray market glp-1 Glucagon-like peptide-1 (GLP-1) injectable medications have shown a lot of promise for managing chronic conditions like diabetes and obesity. But their popularity and price has spurred many lookalikes that are not GLP-1s PART II: The Gray Market

Anodyne Nanotech announced today that it closed a $12.6 million Series A financing to support its transdermal drug delivery technology.

GLP-1 Support Stack

Learn how GLP1 medication relates to midlife weight gain, HRT, muscle loss, appetite, side effects and long-term weight maintenance.

GLP-1 research tablet provides 25 x 7mg tablets of GLP-1 receptor agonist studied in preclinical models for incretin-pathway signaling, metabolic regulation, and energy-balance pathways

One dish to wash, zero transfer required

Evidence from experimental and clinical studies indicates that various diets, including Mediterranean, Nordic, Palaeolithic and ketogenic diets, increase insulin sensitivity, decrease gluconeogenesis, and adiposity, and exert anti-inflammatory effects, thus preserving immuno-metabolic homeostasis in individuals with T2D